miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma.

@article{Weeraratne2011miR34aCC,
  title={miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma.},
  author={Shyamal Dilhan Weeraratne and Vladimir M. Amani and Adrianne Neiss and Natalia Teider and Deborah K Scott and Scott L. Pomeroy and Yoon-Jae Cho},
  journal={Neuro-oncology},
  year={2011},
  volume={13 2},
  pages={
          165-75
        }
}
Recent studies have established miR-34a as a key effector of the p53 signaling pathway and have implicated its role in multiple cancer types. Here, we establish that miR-34a induces apoptosis, G2 arrest, and senescence in medulloblastoma and renders these cells more sensitive to chemotherapeutic agents. These effects are mediated in part by the direct post-transcriptional repression of the oncogenic MAGE-A gene family. We demonstrate that miR-34a directly targets the 3' untranslated regions of… CONTINUE READING
52 Citations
55 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 52 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 55 references

Targeted Therapy in Medulloblastoma

  • Cho Y-J, SL Pomeroy
  • 2010

Similar Papers

Loading similar papers…